[
Home
]
[
Up
]
[
Store Home Page
]
[
Info
]
[
Search
]
[
View Basket
]
[
Checkout
]
[
Send email
]
[
Login
]
Items Ordered:
Cart Value:
New Products:
1.
Advances in Large Scale BioManufacturing and Scale-Up Production
2.
Monoclonal Antibodies Report Part I
3.
Spending on Telehealth Solutions in Europe 2007 to 2012 (Databook)
4.
Spending on Telehealth Solutions in North America through 2007 to 2012 (Databook)
5.
Irritable Bowel Syndrome Potentially profitable market is open for the taking
6.
Supportive Care in Oncology Significant growth opportunities exist in new supportive care indications
7.
Hepatocellular Carcinoma Opportune indication for novel therapies
8.
Generic Series An Introduction to the Canadian Generics Market Key trends and leading companies shaping the market
9.
Female Sexual Dysfunction Results from Datamonitor's 2005 physician survey
10.
The Global Anti-Infectives Market Outlook to 2011
Best Sellers:
1.
Advances in Large Scale BioManufacturing and Scale-Up Production
2.
Vaccines - The World Market
3.
Legal aspects of outsourcing contracts in the pharmaceutical industry: A practical guide
4.
BioNewsCast Press Release Distribution Service
5.
Therapeutic Class Overviews
6.
4th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production
7.
The Cardiovascular Market Outlook to 2011
8.
Preparing Health Technology Submissions for Pharmaceutical Products
9.
Guide to US Reimbursement for Drugs, Medical Devices, and Diagnostics
10.
Computer-Assisted Drug Design Course
World Market for Anti-Infectives, Volume III: Antivirals, The
This volume of Kalorama Informations World Market for Anti-Infectives series focuses on three general product segments of antiviral treatment:
Nucleoside Analogs
Protease Inhibitors
Other Misc. Antivirals
The report covers both currently marketed and late stage development antiviral products in detail. For each segment, the report provides:
An overview
Description of products on the market
Description of products in development
Market estimates and forecasts through 2009
Market segmentation by infection type
Market segmentation by geographic region
Market share of leading suppliers
Market share of leading products
The report also includes statistical (epidemiologic and demographic) information for viral infections by type worldwide, with special emphasis on the United States and describes the major clinical, business, and regulatory trends shaping the global and domestic markets.
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives.
All market data pertains to the world market at the manufacturers level. The base year for data was 2004. Historical data are provided for the years 2002 and 2003, with forecast data provided for 2005 through 2009. Compound annual growth rates (CAGRs) are provided for the 2002-2004, 2004-2009 and 2002-2009 periods for each industry segment covered. Competitive analysis is provided for the year 2004. The forecasted market analysis for 2005-2009 was based on probability of approval and sales of products in late stage development, product marketing, and demographic trends.
June 1, 2005
PDF
136 Pages
Table of Contents
Price: $2,500.00 / GBP1,275.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.